logo

MEI Pharma Secures Over $100 Million Funding Commitment to Launch Litecoin Treasury Strategy

By: theblockbeats.news|2025/07/18 16:42:12

BlockBeats News, July 19th, Titan Partners Group and crypto investment firm GSR are co-leading a strategic transformation of the US pharmaceutical company MEI Pharma (NASDAQ: MEIP), driving the establishment of a dedicated Litecoin treasury strategy. Currently, there has been over $100 million in funding commitments to this project.


It is worth mentioning that Litecoin creator Charlie Lee has agreed to join the MEI Pharma board of directors. Furthermore, the Litecoin Foundation has also invested in MEI Pharma as the company's treasury strategy aligns closely with the Litecoin Foundation's core mission of promoting global Litecoin adoption.

Bitcoin y las altcoins en una encrucijada: ¿nuevos máximos o corrección entrante?
WEEX causa sensación en BlockchainRIO 2025

También te puede interesar

Compartir
copy

Ganadores

Últimas noticias sobre criptomonedas

06:50

Jiangnan Technology Teams Up with SynVista to Launch AI Green Mining Platform

06:48

The US Ethereum Spot ETF experiences 5 consecutive days of net inflows ending, with a net outflow of $79 million yesterday.

05:51

Suspected Ethena Labs Withdraws Another 25 Million ENA

05:48

Yesterday's Whale Trader Who Perfectly Shorted Before the Major Drop Goes Long on ETH with 2x Leverage, Holding a Position Worth $56 Million

05:18

Tom Lee: S&P 500 to Rise to 7300, Surge in Market Liquidity Could Be Explosive

Leer más
Comunitario
icon
icon
icon
icon
icon
icon
icon

Atención al cliente@weikecs

Cooperación empresarial@weikecs

Trading cuantitativo y MM[email protected]

Programa VIP[email protected]